Veterinary Medicines

WORM STOP tablets for dogs

Authorised
  • Fenbendazole
  • Pyrantel embonate
  • Praziquantel
Download as PDF

Product identification

Medicine name:
WORM STOP tablets for dogs
POPANDOG 50/144/200 mg COMPRIMIDOS PARA PERROS
Active substance:
  • Fenbendazole
  • Pyrantel embonate
  • Praziquantel
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Fenbendazole
    200.00
    milligram(s)
    /
    1.00
    Tablet
  • Pyrantel embonate
    144.00
    milligram(s)
    /
    1.00
    Tablet
  • Praziquantel
    50.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AA51
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:
  • Immediate packaging material: PVC/Alu blister or polyethylene container. Package size: carton box containing PVC/Alu blister of 1x2 tablets
  • Immediate packaging material: PVC/Alu blister or polyethylene container. Package size: carton box containing PVC/Alu blister of 3x2 tablets
  • Immediate packaging material: PVC/Alu blister or polyethylene container. Package size: carton box containing PVC/Alu blister of 1x10 tablets
  • Immediate packaging material: PVC/Alu blister or polyethylene container. Package size: carton box containing PVC/Alu blister of 2x10 tablets
  • Immediate packaging material: PVC/Alu blister or polyethylene container. Package size: carton box containing PVC/Alu blister of 10x10 tablets
  • Immediate packaging material: PVC/Alu blister or polyethylene container. Package size: carton box containing PVC/Alu blister of 20x10 tablets
  • Immediate packaging material: PVC/Alu blister or polyethylene container. Package size: Polyethylene container containing 200 tablets.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Pharma World Pharmaceuticals Kft.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Pernix Pharma Kft.
Responsible authority:
  • Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 3169 ESP
Date of authorisation status change:
Reference member state:
  • Hungary
Procedure number:
  • HU/V/0121/001
Concerned member states:
  • Czechia
  • Germany
  • Italy
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Spain

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 6/08/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 6/08/2025
Download